The World Health Summit brings together leading researchers, physicians, government officials, and representatives from industry and civil society worldwide. Speakers at the World Health Summit 2020 include:
Ibrahim Abubakar (MBBS, DPH, MSc, PhD, FFPH, FRCPE, FRCP, FMedSci) is Director of the UCL Institute for Global Health. He led the UCL Centre for Infectious Disease Epidemiology, UCL-TB and was a senior investigator at the MRC Clinical Trials Unit. He was head of TB at Public Health England. Prior to his appointment at UCL, he was Professor in Health Protection at the Norwich Medical School. He qualified in medicine in 1992 and initially trained in general medicine before specialising in public health medicine. His academic public health training was undertaken at the London School of Hygiene and Tropical Medicine, University of Cambridge and the University of East Anglia. He is the chair of Lancet Migration: global collaboration to advance migration health and the Wellcome Trust Expert Review Group on Population Health. He was chair of the WHO Strategic and Technical Advisory Group for Tuberculosis. He serves on/chairs several expert/advisory groups for the WHO and the European Centre for Disease Prevention and Control. In addition to his role as Director of the UCL Institute for Global Health, Prof Abubakar runs a global health research programme that addresses major diseases affecting vulnerable groups. His work focuses on the epidemiology, prevention and treatment of infections including tuberculosis, hepatitides, HIV, and other common problems such as antimicrobial resistance and vaccine preventable diseases particularly among underserved populations.
Marylyn Martina Addo is a German virologist who is a Professor and the German Center for Infection Research (DZIF) Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf. Addo has developed and tested vaccinations that protect people from Ebola virus disease and the MERS coronavirus EMC/2012. She is currently developing a viral vector based COVID-19 vaccine. Addo studied medicine at the University of Bonn. She earned her diploma at the London School of Hygiene and Tropical Medicine, during which she researched Candida albicans transmission between HIV-positive people. In 1999 she moved to Boston, where she specialised in infectious diseases at the Harvard Medical School. In 2013 Addo returned to Germany, where she was made a Professor and the German Center for Infection Research (DZIF) Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf.
Professor Adeyeye is the Director General (DG) of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) where she is leading regulatory and administrative reforms through quality management approach. She has added strong governance structure and regulatory strengthening to NAFDAC through disciplined and motivating workforce, updating of regulations and guidelines, strengthening the local pharmaceutical companies through international best practices and encouraging local production. She currently serves as the Chair of the Steering Committee of the African Medicines Regulatory Harmonization (AMRH) and the WHO-based Global Pediatric Regulatory Network. She represents NAFDAC on the International Coalition of Medicines Regulatory Authorities (ICMRA) and has been invited to be on the WHO Regional Expert Advisory Committee on Traditional Medicine for COVID-19. She is a Fellow of Nigeria Academy of Science, Nigeria Academy of Pharmacy, an Academic Research Fellow of American Association of Colleges of Pharmacy (AACP). She is the First African Woman Fellow, American Association of Pharmaceutical Scientists (AAPS) a society where only 3% of academia receives such recognition internationally.
Dr. Tedros Adhanom Ghebreyesus has been Director-General of the World Health Organization since 2017. Upon assuming office, he outlined five key priorities for the WHO: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO. Tedros is globally recognized as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics. He previously served as Ethiopia’s Minister of Foreign Affairs, Ethiopia’s Minister of Health, and Chair of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
Ann Aerts has been Head of the Novartis Foundation since January 2013. During this time, she has been leading an organization committed to catalyzing innovations that transform the health of low-income populations. Since 2019, the Novartis Foundation sharpened its focus to concentrate on how digital technology, data science and artificial intelligence can reimagine health and care around the world. Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, as well as a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. She also holds a Certificate in Applied Epidemiology from the CDC in Atlanta, US, and a Certificate of Executive Development from the IMD Business School, Lausanne, Switzerland.
Hera Ali is a Clinical Pharmacist based in England, United Kingdom, with an interest for Public Health + Advocacy. Currently, Hera is working as Chairperson of Public Health; advocating for youth engagement and inclusion on a global level at high level meetings such as the WHO World Health Assembly. As Chairperson of Public Health, Hera coordinates the Public Health activities of IPSF on a global level, leading a team of 30 individuals including Regional Project Officers from all five of the IPSF Regional Offices. Hera is also passionate about encouraging interprofessional working from the student level to aid the relations once in professional life. During her time in IPSF has led several campaigns and health initiatives in collaboration with various other healthcare student organisations such as IFMSA, IVSA and IADS.
The Director of ECDC is Dr Andrea Ammon, MD, MPH. She was elected as the new Director of ECDC for a period of five years by the ECDC Management Board on 22 March 2017 and was formally appointed on 16 June 2017. Previously, Dr Ammon was ECDC’s Acting Director from 1 May 2015. Andrea joined ECDC as the Head of the Surveillance Unit in 2005. The unit was responsible for developing The European Surveillance System (TESSy), implementing a long-term surveillance strategy for the European Union (EU), evaluating the Dedicated Surveillance Networks (DSN), performing step-by-step transfer of DSN activities to ECDC, revising the EU case definitions and producing an Annual Epidemiological Report on infectious diseases in the EU. From April 2011 to April 2015, Andrea Ammon was Deputy to the Director and Head of Unit for Resource Management and Coordination. Prior to joining the ECDC, Dr Ammon served in several roles at the Robert Koch-Institute, in Berlin, Germany, most recently as Head of Department for Infectious Disease Epidemiology. In this capacity, she maintained and further developed the German national surveillance system; coordinated the national outbreak response team for current and emerging infections; coordinated emergency planning for influenza; directed the national Field Epidemiology Training Programme; coordinated epidemiological research programmes in infectious diseases and provided scientific advice for government Ministries, Members of Parliament, and the public.
Dr. Amuasi is faculty at the Global Health Department of the School of Public Health, KNUST and also Group Leader of the Global Health and Infectious Diseases Research Group at the Kumasi Center for Collaborative Research in Tropical Medicine which hosts the Secretariat of the African Research Network for Neglected Tropical Diseases (ARNTD) of which he is the Executive Director. Dr. Amuasi trained as a physician at the KNUST School of Medical Sciences, and later graduated from the University of Minnesota School of Public Health, USA, with post-graduate degrees terminating in a PhD in Health Research and Policy. He also served as head of the R&D Unit at the 1,000-bed Komfo Anokye teaching Hospital in Kumasi, Ghana for 3 years from 2007-2010. Dr. Amuasi’s is passionate about research that focuses on improving health systems, services and outcomes, including policy analyses using both primary and secondary data in low and middle-income countries. His research currently involves field epidemiologic studies on cryptosporidiosis, malaria, and some neglected tropical diseases. Dr Amuasi is also at the fore-front of global efforts towards addressing emerging and reemerging infectious diseases and serves as an Executive Committee member of the African Coalition for Epidemic Research, Response and Training (ALERRT).
Niels Annen is a German politician and Minister of State at the Federal Foreign Office. Prior to this, he served as spokesperson on foreign affairs of the SPD Parliamentary Group in the German Bundestag. 2010, Annen joined the German Marshall Fund as a Senior Fellow in Washington, D.C.. Between 2011 and 2013, he served as director of European policy analysis at the Berlin headquarters of the Friedrich Ebert Foundation. Annen holds a bachelor's degree in history from the Humboldt University of Berlin and a master's degree in International Public Policy from the Paul H. Nitze School of Advanced International Studies at Johns Hopkins University in Washington, D.C..
Inger Ashing is Chief Executive Officer (CEO) of Save the Children International. A respected child rights activist, Inger has been associated with Save the Children for more than 25 years, first serving as a youth advocate and later on the Boards of Save the Children Sweden and Save the Children International. Prior to her appointment in September 2019, Inger was Director General at the Swedish Agency against Segregation, a Swedish government agency, where she worked to reduce segregation and social inequality, with a special focus on improving the situation in socio-economically disadvantaged areas. She has also served as the National Coordinator for Youth Not in Education or Employment for the Swedish Government, Deputy Director General of the Swedish Agency for Youth and Civil Society and the CEO of the Global Child Forum. Inger is also a member of the Ethics Council at The Swedish Migration Agency. She has been an expert to and board member of several authorities and committees such as the Delegation for Human Rights, the Swedish National Knowledge Centre on Violence against Children, the Delegation for the Employment of Young People and Newly Arrived Migrants, the Swedish Enforcement Authority, the National Board of Institutional Care, and the Monitoring Committee for The European Social Fund.
Hila Azadzoy is an accomplished social entrepreneur dedicated to using the power of technology for social good. In 2018, Hila joined Ada Health to lead its Global Health Initiative, which is focused on improving the availability and delivery of primary care to underserved populations worldwide. Prior to Ada, Hila was a Founding Member and Head of Academics of Kiron Open Higher Education, an award-winning social startup working to remove the barriers to higher education for refugees worldwide through smart digital solutions. Hila is a recipient of the Digital Female Leader Award, an MIT Solver and a frequent public speaker, having spoken at international forums such as TEDx, Clinton Global Initiative, UNESCO NGO Forum, UBS Social Innovator and World Summit AI.
Michelle Bachelet Jeria assumed her functions as United Nations High Commissioner for Human Rights on September 1, 2018. She is the seventh Commissioner to hold the office, which was established in 1993. Bachelet was previously President of Chile (2006-2010 and 2014-2018), and was the country's first female president. She also served as Chile's Health Minister (2000-2002) an was Latin America’s first female Defense Minister (2002-2004). Prior to her appointment as High Commissioner for Human Rights, Bachelet held a number of UN positions in the areas of women's rights and maternal, newborn, and child health. She has a Medical Degree in surgery, with a specialization in pediatrics and public health.
Dr. Manica Balasegaram is GARDP’s Executive Director and has been instrumental in leading GARDP through its three-year incubation to an independent legal entity, during which time GARDP launched four programmes and built a skilled and dedicated team with expertise from a range of sectors and backgrounds. Manica trained as a medical doctor at the University of Nottingham, UK from where he started his career in internal and emergency medicine. From 2001 onwards, he worked as a doctor and researcher in several countries in Sub- Saharan Africa and Southern Asia. He also gained significant experience working in humanitarian emergencies and responses, largely with Médecins Sans Frontières (MSF). At the end of 2007 he joined the Drugs for Neglected Diseases initiative as Head of Leishmaniasis Clinical Program – a position he held for four years before returning to MSF as Executive Director of their Access Campaign. He was appointed Director of GARDP in June 2016. He is also currently a board member of the Medicines Patent Pool as well as of FIND’s Scientific Advisory Committee. Manica’s experience spans clinical and public health practice in infectious diseases and international work on health policy & access to medicines. He has served on numerous technical and health policy panels and expert groups. He also has substantial experience in conducting and overseeing clinical trials and drug development projects.
Ricardo Baptista Leite MP, MD is a Medical Doctor (ID-trained), member of Portuguese Parliament (Health and Foreign Affairs Committees) and National Spokesperson for Health of Social Democratic Party. He is the President of ‘UNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and Other Infectious Diseases’; a global platform of parliamentarians committed to ending HIV/AIDS, viral hepatitis and other infectious diseases as global health threats by 2030. He is one of six people acknowledged globally by ‘The Economist’ as a ‘HCV Change Maker’ and is the Head of Public Health at Católica University of Portugal, Coordinator of Sustainable Healthcare at NOVA Information Management School and Guest Lecturer at NOVA Medical School. He has also served as the former Deputy Mayor of the city of Cascais.
Dr. Seth Berkley is the CEO of Gavi, the Vaccine Alliance since 2011. He founded the International AIDS Vaccine Initiative (IAVI) in 1996, where he served as President and CEO. Prior to that, he worked for the Health Sciences Division at The Rockefeller Foundation, held posts at the Center for Infectious Diseases, the US Centers for Disease Control; the Massachusetts Department of Public Health; and the Carter Center, where he was assigned as an epidemiologist to the Ministry of Health in Uganda.
Mukul Bhola is Chief Executive of The Defeat-NCD Partnership. A serial entrepreneur, Mukul has more than 19 years of experience as a passionate humanitarian and development practitioner, during which he has led crisis response operations, developed strategic public-private partnerships, and mobilized significant financial resources. Prior to founding The Defeat-NCD Partnership, Mukul headed the Geneva Liaison Office for the Partnerships Group at UNOPS and was also responsible for managing the UNOPS-DFID partnership–growing it to an unprecedented US $250 million of new programmes signed in 2018. Mukul began his United Nations career with the United Nations Information Centre in New Delhi, India in 2000, before moving on to work with the United Nations Development Programme on the Gujarat Earthquake recovery programme, and subsequently its Bureau for Crisis Prevention and Recovery. He co-led – on behalf of the International Labour Organization – four joint United Nations-World Bank post-disaster needs assessments to Bangladesh, Haiti, Madagascar, and Myanmar, and while at the International Labour Organization was seconded to United Nations International Strategy for Disaster Reduction to develop the first biennial joint work programme for the strengthened UNISDR system. With a first-class honours degree in economics, Mukul is highly experienced in working with big data. He spent over five years at the International Federation of Red Cross and Red Crescent Societies. Mukul is a volunteer and life member of the Indian Red Cross, and in 2017 he was requested to support the co-development of their transformational Strategy 2030.
Her previous roles at FIND included Chief Medical Officer (CMO) and Head of the TB program, where she was responsible for clinical evaluation of new tools for diagnosis of TB, malaria and neglected diseases. She has an extensive background in clinical evaluation and played a key role in FIND’s Xpert MTB/RIF feasibility. Prior to joining FIND in 2005, she worked as program coordinator for the Department of Infectious and Tropical Diseases in Munich, Germany, and established a TB research unit at Mbeya Medical Research Program in Tanzania.
Alena Buyx is Professor of Ethics in Medicine and Health Technologies and Director of the Institute of History and Ethics in Medicine at Technical University Munich. She has previously held appointments at the University of Kiel, University of Muenster; Harvard University, and University College London; and she was Assistant Director of the Nuffield Council on Bioethics, London. Professor Buyx is a medical doctor with postgraduate degrees in philosophy and sociology. Her research spans the whole field of biomedical and public health ethics, with a particular focus on ethics of medical innovation and health technologies, research ethics, questions of solidarity and justice in contexts such as public health and health care provision, and novel participatory approaches in biomedicine and beyond. She has expertise in theoretical ethical analysis as well as in empirical, mixed-methods approaches and policy development. She is keen on interdisciplinary approaches and collaborates regularly with clinical colleagues as well as with public health professionals, political and social scientists, philosophers, lawyers or health economists. As a PI, Professor Buyx has been awarded over 3 million Euros over the last five years for dedicated ethics research. Her work is published in high-ranking journals, such as Science, BMJ, GiM or Bioethics. She is an award-winning teacher of medical and life science students, early career researchers, clinicians and health professionals. In addition to research and teaching, Professor Buyx is active in the political and regulatory aspects of biomedical ethics, sitting on a number of high-level national and international ethics bodies concerned with policy development and implementation, and consulting for various international research consortia and policy initiatives. She has been a member of the German Ethics Council since 2016 and a member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing since 2019.
Winnie Byanyima assumed her functions as Executive Director of UNAIDS since 2019.
Prior to that, she has been the Executive Director of Oxfam International and served as the Director of Gender and Development at the United Nations Development Programme.
Ms Byanyima began her career as a champion of marginalized communities and women 30 years ago as a member of parliament in the National Assembly of Uganda. In 2004, she became the Director of Women and Development at the African Union Commission, working on the Protocol on the Rights of Women in Africa, an international human rights instrument that became an important tool for reducing the disproportionate effect of HIV on the lives of women in Africa.
She holds an advanced degree in mechanical engineering (in energy conservation and the environment) from the Cranfield Institute of Technology and an undergraduate degree in aeronautical engineering from the University of Manchester.
Jim Campbell is the director of the Health Workforce department of the World Health Organization. He oversees the development and implementation of global public goods, evidence and tools to inform national and international investments in the health and social sector workforce in pursuit of global health security, universal health coverage and the Sustainable Development Goals. The department’s recent work includes WHO Guidelines on Community Health Workers, Global Strategy on Human Resources for Health: Workforce 2030, the report of the High-level Commission on Health Employment and Economic Growth and the subsequent adoption of the ILO, OECD, WHO action plan on Working for Health to implement the Commission’s recommendations. He coordinates the Global Health Workforce Network engaging Member States and relevant partners in WHO’s work.
Emanuele Capobianco is the Director of Health and Care at the International Federation of the Red Cross and Red Crescent Societies (IFRC). He leads the IFRC global Health and Care Team that provides strategic and operational support to 192 National Red Cross and Red Crescent Societies around the world in the areas of community health, emergency health and water/sanitation. He currently leads the IFRC global response to COVID19 and the IFRC response to the Ebola outbreaks in DRC. Emanuele brings 20 years of experience in policy development and implementation of health programmes in low and middle-income countries with specific expertise in fragile settings, partnerships, maternal/child health and communicable diseases. Before joining IFRC he served as the Deputy Executive Director of the Partnership for Maternal, Newborn & Child Health and as Senior Policy Advisor with the Global Fund, coordinating the development of the 2017-2022 Global Fund Strategy and the first Global Fund policy on fragile settings. Emanuele worked with the World Bank, UNICEF and WHO in Mozambique, Somalia, Afghanistan and India where he managed programmes on communicable diseases, mother and child health, nutrition, and drug use prevention, treatment and care. Emanuele has a Medical Degree from Italy, a Master in Public Health from Johns Hopkins University and an Erasmus Mundus’ Master in International Humanitarian Action.
Dr Margaret Chan is the Director-General Emeritus of the World Health Organization (WHO). As the 7th Director-General from January 2007 to June 2017, Dr Chan led WHO through a period of profound change. The political, social, economic and epidemiological challenges facing health in the early 21st century have been unprecedented in their complexity and global in their impact. Population ageing, antimicrobial resistance, climate change, obesity, and the globalised marketing of unhealthy products, chronic non communicable diseases overtook infectious diseases as the leading killers worldwide. The global economic slowdown since 2008 also affected populations around the world as many governments struggled to finance basic health services. Despite these immense challenges, Dr Chan's leadership ensured sustained progress in improving health and life-expectancy in populations around the world. During her tenure, Dr Chan led the global movement on 'universal health coverage', and the global response to major health emergencies like the influenza pandemic, Ebola and Zika epidemics. She has also transformed WHO into one of the most transparent and accountable international organisations by initiating an ambitious program of reform since 2011. As Director-General, Dr Chan frequently emphasised the importance of working in partnership with other stakeholders in society to achieve common goals in health. Dr Chan was appointed in March 2018 as a Standing Committee member of the Chinese People’s Political Consultative Conference (CPPCC) in China. In July 2018, she is serving as the President of the Global Health Forum under the Boao Forum for Asia.
Nanette Cocero is the Global President of Pfizer Vaccines, leading the development, commercialization and delivery of innovative vaccines to drive the prevention of serious and life-threatening conditions. With over 25 years of experience in diverse leadership positions, Nanette is a recognized global leader with broad business acumen coupled with an extensive clinical background and scientific expertise. Nanette’s experience includes leading global teams of 3,500+ colleagues and managing diverse portfolios. In her current role, Nanette leads a $6B global business and manages a diverse vaccines portfolio aimed at protecting lives at all stages, from infants to older adults. In addition to vaccines, Nanette’s vast expertise includes working across multiple therapeutic areas within Specialty and Primary Care.
Francesca Colombo, M.Sc., is Head of the Health Division at the Organisation for Economic Cooperation. She is responsible for OECD work on health, which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, advising policy makers, stakeholders and citizens on how to respond to demands for more and better health care and make health systems more people centred. Major activities under her responsibility cover the response to the COVID-19 crisis and solutions to make health systems more resilient; trends in health spending; measuring of health care outcomes, activities and inputs; health care quality policies; assessing health system efficiency and value for money; health workforce; long-term care systems and ageing; the economics of public health; pharmaceutical policies, new technologies, big data and Artificial Intelligence in health. Major publications resulting from the work of the Division she manages include Health at a Glance, Health in the 21st Century: Putting Data to Work for Stronger Health Systems, Realising the Full Potential of Primary Health Care, Attracting and Retaining Care Workers for the Elderly, Tackling Wasteful Spending on Health, The Heavy Burden of Obesity, Making Mental Health Count. Mrs Colombo has over 20 years of experience leading international activities on health and health systems. Over her career, she travelled extensively in Europe, South America and Asia, advising governments on health system policies and reforms.
Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years Thomas Cueni has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. He represented the industry on the EU High Level Pharmaceutical Forum, was Chairman of EFPIA’s Economic and Social Policy Committee and Chairman of the EFPIA Task Force on the EU Commission’s Pharmaceutical Sector Inquiry. Thomas Cueni also represented Interpharma, which he successfully transformed from the association of Swiss Rx companies to the association of pharmaceutical research companies in Switzerland, on the Council of IFPMA. Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist.
Dame Sally is UK Special Envoy on Antimicrobial Resistance. Before this, she was Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010. Dame Sally advocates globally on AMR. She has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side event in 2016. She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR. Most recently, Dame Sally has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016. Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016 and has led delegations to a range of WHO summits and forums since 2004.
Bart de Witte, is one of Europe's leading and awarded experts on the digital transformation of healthcare, and one of the most progressive forward thinkers focuses on finding alternative European strategies for the current postmodern world to create a more desirable future with greater social benefits. He is the initiator of the HIPPO AI Foundation project (in stealth) in Berlin, which focusses on creating data commons and aims to make artificial intelligence in medicine a common good. With his mission to use technology for the greater good, Bart has been on a mission to harness the power of artificial intelligence to help to solve current and future inequalities in healthcare. He wrote his first paper on Artificial Intelligence in 1989 while he was on grammar school, and restated his interest in 2010, while working for IBM. He is part of the founding faculty of the European Institute of Exponential Technologies and Desirable Futures, futur.io. He is involved as a mentor for dozen digital health start-ups. Bart de Witte holds degrees from different universities in Belgium and has followed several other post-university tracks at national and international business schools, including Harvard Business School and Fontainebleau INSEAD. He co-founded the Digital Health Academy where he shares his knowledge to improve digital literacy. Prior to focussing on working for the greater good, he worked as an executive for IBM for eight years - most recently as Director Digital Health at IBM for Germany, Austria and Switzerland - and before that for nine years at SAP Switzerland, including as Business Development Director.
Dr. Roopa Dhatt is a physician by training and an advocate by principle, striving for greater health and well-being for all people through working in global health. She is the Executive Director and co-founder of Women in Global Health, a movement that strives to bring greater gender equality to global health leadership. Since its foundation Women in Global Health, an organization staffed entirely by volunteers, has expanded to become a global movement, with chapters in four continents and more than 21,000 followers in 90+ countries.
Professor Yvonne Doyle joined Public Health England in December 2012. Yvonne Doyle qualified as a doctor and has worked in senior roles in the NHS and Department of Health and Social Care (DHSC), and in the academic and independent sectors. Between 2013 to 2019 she provided leadership for health and reduction of inequalities at city-wide level to the population of London and was Statutory Adviser to the Mayor of London. In 2019 Yvonne was appointed Medical Director and Director of Health Protection for Public Health England. She has acted as an adviser to the WHO on healthy cities and continues to take a research interest in urban health and the environment. In 2016 Yvonne was appointed a Companion of the Order of the Bath for services to public health.
Christian Drosten is the Director of the Institute of Virology of the Charité - Universitätsmedizin Berlin. This year he has become an internationally respected COVID-19 expert. In 2003 he discovered the unknown virus causing SARS and developed a diagnostic test that enabled public health authorities worldwide to stop a beginning pandemic. Drosten has co-authored more than 300 peer-reviewed papers and coordinated research consortia funded by the European Union, Deutsche Forschungsgemeinschaft, and the German Ministry of Research. He is a member of the internal advisory board of the German Center for Infection Research (DZIF) and the speaker of the German National Research Network for Zoonotic Infections. He received the German Federal Cross of Merit for his work to counter the SARS epidemic.
Prof. Dr. Victor Dzau is the President of the National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. His pioneering research in the field of cardiovascular medicine and genetics has made significant impact on medicine and health.
Her Excellency Amira Elfadil Mohammed Elfadil was elected the Commissioner for Social Affairs at the 28th Ordinary Session of the Assembly of the African Union in 2017. Before being elected as Commissioner she served the Government of the Republic of the Sudan as Minister of Welfare and Social Security between 2010 and 2013 and as Minister for Social Affairs for the Khartoum State Government between 2009 and 2010. She served as Member of Parliament and was on the Foreign Relations Committee from 2015 until she assumed her current role. With her passion in addressing children, girls and women’s empowerment issues, she has held various senior roles in the Sudanese Women General Union, was Director General of the Society Studies Centre in Khartoum and Secretary General in the Sudan National Council for Child Welfare in addition to chairing various committees and boards on social development.
Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation (both politically and financially independent) which exists to improve health for everyone by helping great ideas to thrive. Jeremy is a clinician scientist who before joining Wellcome was, for eighteen years, Director of the Clinical Research Unit in Viet Nam, where his research interests were in infectious diseases, tropical health and emerging infections. He has contributed to almost 600 peer-reviewed scientific papers and served on several global advisory committees. In 2015 he was recognised by Fortune magazine as 12th in the top 50 of the World’s Greatest Leaders.
Dr. Maria Flachsbarth joined the Christian Democratic Union of Germany (CDU) in 1991. She became a member of the German Parliament in 2002. Since 2006, she has been deputy chair of the CDU in the state of Lower Saxony, and since 2007, she has chaired the CDU district association for Hanover. From 2002 to 2013, she served on the Parliamentary Committee on the Environment, Nature Conservation and Nuclear Safety. From 2009 to 2013, she chaired a Parliamentary Committee of Inquiry on the envisaged radioactive waste disposal facility at Gorleben, and she was the special representative for churches and religious communities of the CDU/CSU parliamentary group. Then from the end of 2013 to March 2018, she served as Parliamentary State Secretary to the Federal Minister of Food and Agriculture. Since March 2018, she has been Parliamentary State Secretary to the Federal Minister for Economic Cooperation and Development.
Henrietta H. Fore has been UNICEF’s Executive Director since 2018. She has worked to champion economic development, education, health, humanitarian assistance and disaster relief in a public service, private sector and non-profit leadership career that spans more than four decades. She has previously served as Administrator for USAID and Director of United States Foreign Assistance, Undersecretary of State for Management at the US Department of State, Director of the United States Mint in the US Department of Treasury, and Chair of the Board and Chief Executive Officer of Holsman International, a manufacturing and investment company.
Dr. Frieden is a physician trained in internal medicine, infectious diseases, public health, and epidemiology. He began his public health career in New York City confronting the largest outbreak of multi-drug resistant tuberculosis to occur in the US. He was then assigned to India, on loan from the Centers for Disease Control and Prevention, where he helped scale up a program for effective tuberculosis diagnosis, treatment, and monitoring. Asked to return to New York City to become Mayor Mike Bloomberg’s Health Commissioner, he directed efforts to reduce smoking and other leading causes of death that increased life expectancy by 3 years. As Director of the US Centers for Disease Control and Prevention, Dr. Frieden oversaw the work that helped end the 2014 West Africa Ebola epidemic. Dr. Tom Frieden now leads Resolve to Save Lives, a $225 million, 5-year initiative of Vital Strategies, which aims to save millions of lives from cardiovascular disease and make the world safer from epidemics.
Tomaž Gantar, born on 21 March 1960, graduated from the Faculty of Medicine in Ljubljana in 1987 and specialised in urology in 1994. Through his many years of work in healthcare he obtained expertise and experience in the organization, operation, financing and management of the healthcare system. He has attended numerous professional meetings in Slovenia and abroad. He was the managing director of the Izola General Hospital from 1999 to 2004 and the mayor of the Municipality of Piran from 2006 to 2010. Mr Gantar was a member and chair of several supervisory boards and institute councils. He was the Minister of Health in 2012 and 2013 and a deputy of the National Assembly of the Republic of Slovenia in the 2014–2018 term. During that time, he was also the chair of the Committee on Health of the National Assembly. Afterwards, he worked as a specialist doctor and head of the urology department at the Izola General Hospital.
George F. Gao is a Chinese virologist and immunologist. He has served as Director of the Chinese Center for Disease Control and Prevention since 2017 and Dean of the Savaid Medical School of the University of Chinese Academy of Sciences since 2015. Gao is an academician of the Chinese Academy of Sciences and The World Academy of Sciences, as well as a foreign associate of the US National Academy of Sciences and the US National Academy of Medicine. He was awarded the TWAS Prize in Medical Science in 2012 and the Nikkei Asia Prize in 2014.
Dr. Stefan Germann is the CEO of Fondation Botnar, which works to improve the health and wellbeing of children and young people in growing secondary cities, connecting diverse partners and investing in solutions that leverage AI and digital innovation. Germann was previously Executive Director of onegoalglobal.org, an innovative collaborative child nutrition and healthy lifestyle campaign, and Senior Director of the World Vision International Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia. He has also held several board and advisory board memberships.
Lawrence O. Gostin is University Professor, Georgetown University’s highest academic rank, and Founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law. Gostin is Professor of Medicine at Georgetown University and Professor of Public Health at Johns Hopkins University. The WHO Director-General appointed Prof. Gostin to high-level positions, including expert panels on the International Health Regulations (IHR) and on Mental Health. He served on the Director-General’s Advisory Committee on Reforming WHO, as well as WHO expert advisory committees on pandemic influenza, smallpox, genomic sequencing, and migrant health. He served on WHO’s Blue Ribbon Panel on global health equity. He co-chairs the Lancet Commission of Global Health Law.
IAEA Director General Rafael Mariano Grossi assumed office on 3 December 2019. Mr Grossi is a diplomat with over 35 years of experience in the field of non-proliferation and disarmament. In 2013, he was appointed Ambassador of Argentina to Austria and Argentinian Representative to the IAEA and other Vienna-based International Organizations. In 2019, Mr Grossi acted as President Designate of the 2020 Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT), and from 2014 to 2016 he served as president of the Nuclear Suppliers Group, where he was the first president to serve two successive terms. In 2015, he presided over the Diplomatic Conference of the Convention on Nuclear Safety, securing unanimous approval for the Vienna Declaration on Nuclear Safety – a milestone in international efforts in the wake of the 2011 FukushimaDaiichi nuclear accident.
António Guterres, the ninth Secretary-General of the United Nations, took office on 1st January 2017. Prior to his appointment as Secretary-General, Mr. Guterres served as United Nations High Commissioner for Refugees from June 2005 to December 2015, heading one of the world’s foremost humanitarian organizations during some of the most serious displacement crises in decades. Before joining UNHCR, Mr. Guterres spent more than 20 years in government and public service. He served as prime minister of Portugal from 1995 to 2002, during which time he was heavily involved in the international effort to resolve the crisis in East Timor. As president of the European Council in early 2000, he led the adoption of the Lisbon Agenda for growth and jobs, and co-chaired the first European Union-Africa summit. He was a member of the Portuguese Council of State from 1991 to 2002.
Dr. Hader brings to the position more than 20 years of international experience in global health - from responding to HIV and infectious diseases to strengthening health systems. She has served in key health leadership roles emphasizing accountability, scale and impact for sustainable responses. In 2014, Dr Hader was appointed Director of the Division of Global HIV and TB, US Centres for Disease Control and Prevention (CDC) providing technical leadership, funding, evaluation and programme support to help achieve an AIDS-free generation world-wide. Prior to this position, she served as Vice President and Director for the Centre for Health Systems and Solutions at the Futures Group (now Palladium). Dr. Hader also held the position of Senior Deputy Director, HIV/AIDS, Hepatitis, STD and TB Administration for the District of Columbia from 2007–2010 and served as Director of CDC–Zimbabwe from 2003–2006. A public health physician, Dr Hader’s career has reached across research, programme, policy and politics. She holds a degree in Biological Sciences from Stanford University and MD and MPH degrees from Columbia University. Dr. Hader is board certified in Internal Medicine, Paediatrics and Infectious Diseases.
Sir Andrew Haines is Professor of Environmental Change and Public Health at LSHTM, with a joint appointment in the Department of Public Health, Environments, and Society and in the Department of Population Health. He was previously Director (originally Dean) of LSHTM for nearly 10 years, and before that Professor of Primary Health Care at University College London. He worked part-time as a general practitioner in North London for many years and has been a member of a number of major international and national committees. Haines was knighted in 2005 for his services to medicine.
Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that finances and co-ordinates the development of vaccines against emerging infectious diseases with pandemic or epidemic potential. Prior to joining CEPI, Dr. Hatchett served as the U.S. Biomedical Advanced Research and Development Authority’s (BARDA) Chief Medical Officer and Deputy Director. Following this he became acting Director of BARDA. Previously, Dr. Hatchett served on the Homeland Security Council under President George W. Bush and was a member of the National Security Staff under President Barack Obama.
Gerald Haug is the President of the Deutsche Akademie der Naturforscher Leopoldina – German National Academy of Sciences, Halle (Saale) since 2020. He is a paleoclimatologist, marine geologist and paleoceanographer and Professor for Climate Geochemistry, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. He studies the development of the Earth climate over thousands to millions of years. He analyses sediment cores from the sea floor and lakes, amongst several other climate archives. The chemical composition of the different sediment layers provides clues to the prevailing climatic conditions at the time of deposition. This allows quantitative reconstructions of past climate conditions and the underlying processes in the ocean, atmosphere and climate system.
Myint Htwe was appointed as Minister of Health and Sports by the Government of the Republic of the Union of Myanmar in April 2016. He has spent over 16 years with WHO, serving in a variety of roles in the South East Asia Regional Office, including Regional Advisor for Research and Policy Cooperation and Director for Programme Management. Before he joined WHO’s Regional Office, he was at the Ministry of Health, where he served as Chief of the Health Systems Research Unit and Chief of the International Health Division of the Minister’s Office. Minister Htwe is a former member of the Executive Committee of the Myanmar Academy for Medical Sciences. He has held a number of key positions including Chair of the Preventive and Social Medicine Society of the Myanmar Medical Association, and Chair of the Ethics Review Committee of the Department of Medical Research at the Ministry of Health. Minister Htwe holds a medical degree and a Diploma in Preventive and Tropical Medicine from the Institute of Medicine in Myanmar, a Masters in Public Health from the University of the Philippines and a Doctorate in Public Health from the Johns Hopkins University in the USA.
Paul Hudson joined Sanofi as CEO on September 1, 2019. Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has an expansive international career in healthcare that spans the U.S., Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca United States and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo U.K. Paul holds a degree in economics from Manchester Metropolitan University in the U.K. and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the U.K.
Dr. Rachel Huxley is Director of Knowledge and Learning, responsible for C40’s knowledge management strategy and research program. Rachel has been with C40 for over 4 years during which time she has developed and led a priority program of research on the multiple benefits of urban climate action and overseen the launch of C40’s flagship Knowledge Hub. Prior to this Rachel was Chief Executive of Peterborough Environment City Trust, leading the Trust’s work on sustainable behavior change and engagement project delivery, as well as, working strategically with city partners to develop a sustainable city plan. As part of her work on sustainable cities Rachel established and led the Sustainable Cities Network, an informal network of leading UK cities to enable sharing of best practice and challenges. Rachel has a PhD from the University of Leeds on the processes and practices of sustainable transition and decision making in cities.
Before joining WHO, Ms Elizabeth Iro had more than 30 years of experience in public health in the Cook Islands and regionally. As Secretary of Health of the Cook Islands, she implemented health reforms to strengthen the country’s health system. These include developing the country’s National Health Roadmap 2017-2036, the National Health Strategic Plan 2017-2021, and the Health Clinical Workforce Plan. She had previously served as the country’s Chief Nursing Officer and Acting Director of Hospital Health Services. For the first 25 years of her career, she was a staff nurse, midwife and charge midwife at hospitals in the Cook Islands and New Zealand.
Dr. Jayasree K. Iyer leads the Access to Medicine Foundation as Executive Director, directing strategy, stakeholder dialogues, and research programs. As a spokesperson, she is actively involved in stimulating change within the pharmaceutical industry. She has worked at the interface of the global health community and the pharmaceutical industry for 12 years. Before joining the Foundation, Iyer was responsible for creating, negotiating, and managing public private partnerships in R&D for infectious diseases and oncology. She has worked at NGOs, academic institutions and think tanks.
Ylva Johansson is a Swedish politician who has been serving as European Commissioner for Home Affairs since 2019. She previously served in the government of Sweden as Minister for Schools from 1994 to 1998, as Minister for Welfare and Elderly Healthcare from 2004 to 2006, and as Minister for Employment from 2014 to 2019. She has been a member of the Swedish Riksdag since 2006.
Dr. Natalia Kanem is the Executive Director of the United Nations Population Fund (UNFPA), the United Nations sexual and reproductive health and rights agency. Appointed by United Nations Secretary-General António Guterres in 2017, Dr. Kanem has more than 30 years of strategic leadership experience in the fields of preventive medicine, public and reproductive health, social justice and philanthropy. Dr. Kanem holds a medical degree from Columbia University in New York, and a Master’s degree in Public Health with specializations in epidemiology and preventive medicine from the University of Washington in Seattle. She is a magna cum laude graduate of Harvard University in history and science.
Hon. Given Katuta is a Member of Parliament of the National Assembly of Zambia. She was elected to head the Inter Parliamentary Union IPU Advisory Group on Health in 2019. The Advisory Group's main focus is to end the HIV/AIDS epidemic and aims to significantly improve the health of women and children in different parts of the world. It is part of the overall commitment to health and to help achieve the UN Sustainable Development Goals.
After holding several positions including Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. Since 2019 he is Director Emeritus at this institute. The Microbiology and Immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.
Annette Kennedy is the 28th President of the International Council of Nurses (ICN). She previously served as Third Vice President of the International Council of Nurses (ICN) from 2013-2017 and President of the European Federation of Nurses (EFN) from 2005-2007. Ms Kennedy, an Irish nurse, who was Director of Professional Development at the Irish Nurses and Midwives Organisation from 1994-2012, has extensive experience in dealing with policy issues at high levels and has long been involved with ICN through her vice-presidency and through her work as the President of the European Federation of Nurses (EFN) and as director of professional development for 19 years in the Irish Nurses and Midwives Organisation (INMO).
Prof. Ilona Kickbusch’s work focuses on the political determinants of health, health in all policies, and global health. She established the Global Health Centre at the Graduate Institute and served as its director until 2019. She advises countries on global health strategies and trains health specialists and diplomats in global health diplomacy. Among other positions, Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin. She has had a distinguished career with the WHO and chairs the international advisory board for the development of the German global health strategy.
Dr Marie-Paule Kieny is the treasurer at Santé mondiale 2030. She is currently Director of Research at Inserm (Institut national de la santé et de la recherche médicale) in Paris and also holds positions as President of the Board of Directors of the Medicines Patent Pool Foundation and of DNDI (Drugs for neglected diseases initiative). Until June 2017, Dr Kieny served as the Assistant Director-General for Health Systems and Innovation at the World Health Organization. She also directed the WHO Initiative for Vaccine Research from 2001 to 2010. Key successes under her leadership roles at WHO include the development and licensing of new vaccines against bacterial meningitis, addressing global supply of pandemic influenza vaccine especially in developing countries through technology transfer and manufacturing, and vaccines against poverty-related diseases. Before joining WHO, Dr Kieny held top research positions in the public and private sectors in France which included Assistant Scientific Director of Transgene S.A. from 1981 to 1988 and Director of Research and Head of the Hepatitis C Virus Molecular Virology Group at the Institute of Virology, (INSERM) from 1999 to 2000. Dr Kieny received her PhD in Microbiology from the University of Montpelier (1980), where she was also awarded a University Diploma in Economics, and her Diplôme d’Habilitation à Diriger des Recherches from the University of Strasbourg in 1995. She has published over 350 articles and reviews, mainly in the areas of infectious diseases, immunology, vaccinology, and health systems.
Professor Dame Donna Kinnair is a British nurse and has been Chief Executive and General Secretary of the Royal College of Nursing since August 2018. She has specialised in child protection, providing leadership in major hospital trusts in London, teaching, and advising on legal and governmental committees. Kinnair has had several senior positions in the healthcare sector. She has also taught medical law, ethics and child protection in multiple countries including Britain, New Zealand, Russia and Kenya. In addition, she has provided advice to the UK government on nursing and midwifery through her work with the prime minister's commission in 2010. Kinnair was appointed Head of Nursing of the Royal College of Nursing in 2015 after which she was promoted to Director for Nursing, Policy and Practice in 2016. In August 2018 she was appointed acting Chief Executive and General Secretary before being confirmed on a permanent basis in April 2019.
Joakim Larsson is a Professor in Environmental Pharmacology at the Department of Infectious Disease, University of Gothenburg, Sweden. He received his PhD in animal physiology in 2000 in Gothenburg, and after two years of guest research at marine labs in Canada and USA, he decided to combine his interest for the environment with medicine. He became associate professor in human physiology in 2007 and full professor in 2013. From 2016 he is director for the multidisciplinary Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, involving more than 100 researches from six faculties. Larsson has (co)-authored more than 150 papers, and he is among the 1% most highly cited researchers on Web of Science according to Clarivate Analytics. His earlier work on environmental pollution from drug manufacturing, and his research on selective concentrations of antibiotics has contributed various management initiatives across the world. The research of his own research group focusses today mainly on the environmental dimensions of antibiotic resistance. Current research projects include e.g. research on: the role of antibiotics and biocides in the development (selection, transfer) of antibiotic resistance; understanding the evolutionary history of antibiotic resistance acquisition in pathogens; exploration of the environmental resistome for novel resistance genes; surveillance of resistance in the human population using sewage bacteria; environmental transmission of resistant pathogens; as well as both technical and societal measures to reduce environmental pollution with antibiotics and antibiotic resistant bacteria.
Professor Depei Liu's central research interests are medical molecular biology and research in gene regulation. He executes various prestigious positions, including former President of the Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC).
Bernardo Mariano Junior is the Chief Information Officer at the World Health Organization. In this role, he is responsible for coordinating WHO’s digital health vision and strategy. He leads and oversees all aspects of information technology, data security, and enterprise applications, ensuring WHO is advancing its digital capabilities to deliver its global health goals effectively.
Dr Bente Mikkelsen is Director of the Division of Noncommunicable Diseases and Promoting Health through the Life-course at the World Health Organization Regional Office for Europe. She was formerly Head of Secretariat for the Global Coordination Mechanism on the prevention and control of noncommunicable diseases (WHO GCM/NCD) at the World Health Organization Headquarters (Geneva, Switzerland) from its inception in 2014 as well as a former CEO of the Southern and Eastern Norway Regional Health Authority. Dr Mikkelsen is trained as a Gynaecologist and Obstetrician and holds a Master’s degree in Health Administration and Management from the University of Oslo. Her current focus is on achieving the SDGs through the reduction of premature deaths from NCDs and Promoting health through the life-course in the context of WHO General Programme of Work, Health 2020 and working across sectors with multistakeholders, within and beyond the health sector using innovation, implementation research, health literacy and new technologies.
Jeni Miller joined the Global Climate and Health Alliance in October 2016. Dr Miller leads the day-to-day work of the Alliance, implementing its strategic direction and representing the Alliance publicly. In addition to her role at the Alliance, Dr Miller currently serves as Chair-Elect of the Environment Section of the American Public Health Association. Dr Miller has over fifteen years’ experience working on place-based, policy- and systems-change strategies to improve community environments for health, on leading initiatives addressing childhood asthma prevention, obesity prevention, climate change, health equity, and healthy community redevelopment.
Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX. Bernd Montag joined Siemens in 1995, after completion of his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earning a Ph.D. in theoretical multi-particle physics. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.
Gerd Müller is Germany's Federal Minister for Economic Cooperation and Development. Prior to his current post, Gerd Müller held positions as Parliamentary State Secretary to the Federal Minister of Food, Agriculture, and Consumer Protection and Deputy Head of the Office for Foreign Relations of the Hanns Seidel Foundation. He holds a master's degree in business education.
Juergen Mueller is a member of the Executive Board of SAP SE, leading the Technology and Innovation board area. As Chief Technology Officer (CTO), he is in charge of SAP’s overall platform and technology development, the Business Technology Platform (BTP). The BTP is a portfolio of integrated solutions that accelerate the transformation of data into business value. It includes database and data management, application development, integration and analytics as well as intelligent technologies – from on-premise to the cloud. Moreover, Juergen leads SAP’s overall innovation agenda and builds new business model- and market-driven innovations supporting our customers’ goals and long-term growth strategies.
Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries. He manages the foundation’s disease-specific R&D investments in HIV, tuberculosis, malaria, pneumonia, enteric and diarrheal diseases and neglected tropical diseases. He also manages cross-cutting product development programs, including Discovery & Translational Sciences, Innovative Technology Solutions, Integrated Development, and Vaccine Development & Surveillance. This work relies on close collaboration with an international network of grantees and partners. Trevor spearheaded the creation of the Bill & Melinda Gates Medical Research Institute, and in 2020 he has led the foundation’s efforts to support the development of diagnostics, therapeutics, and vaccines for the global response to COVID-19.Prior to joining the foundation in 2011, Trevor was global head of development with Novartis and previously was involved in clinical research at Pfizer and Parke-Davis. Born and raised in South Africa, Trevor earned his bachelor’s and medical degrees from the University of the Witwatersrand in Johannesburg. He also studied mathematics, logic and philosophy as a Rhodes Scholar at Oxford University, and he earned a Ph.D. in mathematics at the University of Chicago.
Dr Daniel Ngamije was appointed Minister of Health of Rwanda in February 2020. Until then he was the director for malaria and neglected tropical diseases in WHO’s Country Office, based in Kigali. Daniel has over 20 years of experience in the health sector, having held a wide range of leadership positions.
Dr. John Nkengasong is Director of the African Centres for Disease Control and Prevention. Until recently he was the Associate Director for Laboratory Science and Chief of the International Laboratory Branch at the Division of HIV & TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta. In addition, Dr. Nkengasong co-chairs the US President’s Emergency Plan for AIDS Relief’s (PEPFAR) Laboratory Technical Working Group and serves as the founding chair of Board of Directors for the African Society for Laboratory Medicine.
Carlos A. Nobre is an Earth System scientist from Brazil. He graduated in Electronics Engineering from the Aeronautics Institute of Technology (ITA), Brazil, in 1974 and obtained a PhD in Meteorology from the Massachusetts Institute of Technology (MIT), USA, in 1983. He dedicated his scientific carrier mostly to Amazonian and climate science at Brazil’s National Institute of Amazonian Research (INPA) and National Institute of Space Research (INPE). He is a former National Secretary of R&D of Ministry of Science and Technology of Brazil and former President of the Federal Agency for Post-Graduate Education-CAPES. He is foreign member of the US National Academy of Sciences, member of the Brazilian Academy of Science and of the World Academy of Science. He was awarded the Volvo Environmental Prize in 2016, the Von Humboldt Medal of EGU in 2010 and was one of the authors of IPCC AR4 awarded with the Nobel Peace Prize in 2007.
As a Strategic Advisor to the InterAction Council, Joanna is advancing a collaborative partnership on ‘One Health for People and Planet’. This builds upon her former role as Head of Health and Education for the Commonwealth, providing strategic leadership to Ministers across 52 countries, strengthening national systems and capacity for the Education and Health Sectors to enhance security and sustainable development. From 2005- 2014, Joanna worked for the UK Government, and during this time, as national lead for Public Mental Health and Well-Being, developed multi-sector policies across the life-course, to promote wider well-being. From 2010, Joanna worked for the WHO, strengthening capacity on national climate change assessments and strategies in Central Asia; this built upon her earlier national responsibility for heatwave and cold weather planning. Joanna then led on the implementation of the European Action Plan for Public Health, creating partnerships to strengthen public health systems across 53 countries; this was further developed into the World Federation of Public Health Associations ‘Charter for the Public’s Health’ and Implementation tool. Over her career, Joanna has gained experience at local, regional, national and international levels, on addressing inequalities and tackling the social and environmental determinants of health. Across her career, Joanna has gained community based experience working in India, Mexico, Central America and Europe, and in 2003 worked with the WHO in Geneva on gender and violence prevention. Initially qualifying as a medical doctor and training in Primary Health Care, before specialising in Public Health and more latterly, receiving a PhD on Policy.
Tolullah Oni is a Public Health Physician Scientist and urban epidemiologist, a Clinical Senior Research Associate and joint lead of the Global Public Health at the University of Cambridge MRC Epidemiology Unit, and Honorary Associate Professor in Public Health at the University of Cape Town. Born in Lagos, she completed her medical training at University College London, postgraduate medical training in the UK and Australia, a Masters degree in Public Health (Epidemiology) at the University of Cape Town, and a research doctorate in Clinical Epidemiology at Imperial College London. She leads the Research Initiative for Cities Health and Equity (RICHE) conducting transdisciplinary urban health research generating evidence to support development and implementation of healthy public policies in rapidly growing cities, with a focus on Africa. She serves on several advisory boards including Future Earth and the African Academy of Science Open Research Platform; and is an editorial board member of Lancet Planetary Health, Cities and Health, and the Journal of Urban Health. Profiled in the Lancet (2016), Science magazine (2018), and the British Medical Journal (2019), she is a Fellow of the African Academy of Sciences, past co-chair of the Global Young Academy, 2015 Next Einstein Forum Fellow, and a 2019 World Economic Forum Young Global Leader.
Muhammad Ali Pate is the Global Director, Health, Nutrition and Population (HNP) Global Practice of the World Bank and the Director of Global Financing Facility for Women, Children and Adolescents (GFF), based in Washington DC. Dr. Pate, a U.S. and Nigerian national, was until recently the Chief Executive Officer of Big Win Philanthropy, based in the UK, and prior to that held several senior positions, including that of Minister of State for Health in the Federal Republic of Nigeria. He was previously in the World Bank Group where he joined as a Young Professional in 2000 and worked on health issues in several regions including Africa and the East Asia and Pacific. Dr. Pate is an MD trained in both Internal Medicine and Infectious Diseases, with an MBA from Duke University. Prior to this he studied at the University College London. He also has a Masters in Health System Management from the London School of Hygiene & Tropical Medicine, UK.
Céline Pulcini (MD, PhD) is Full Professor of Infectious Disease in Nancy, France. She has been coordinating the French Antimicrobial Resistance national action plan at the Ministry of Health since January 2019. Professor Pulcini was Chair of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antimicrobial stewardship. She is or has recently served also as Expert for the ECDC and the WHO. She has authored or co-authored over 220 international publications. She received in 2017 the ESCMID Young Investigator Award.
Dr. Mike Ryan has been at the forefront of managing acute risks to global health for nearly 25 years. He served as Assistant Director-General for Emergency Preparedness and Response in WHO's Health Emergencies Programme from 2017 to 2019. Dr. Ryan first joined WHO in 1996, with the newly established unit to respond to emerging and epidemic disease threats. He has worked in conflict affected countries and led many responses to high impact epidemics. He completed medical training at the National University of Ireland, Galway, a Master’s in Public Health at University College Dublin, and specialist training in communicable disease control at the Health Protection Agency in London and the European Programme for Intervention Epidemiology Training.
A former Chief Executive Officer of Standard Chartered PLC, Sands has been a research fellow at Harvard University since 2015, working on a range of research projects in financial markets and regulation, fintech, and global health. His engagement with global health issues includes chairing the US National Academy of Medicine's Commission on a Global Health Risk Framework for the Future, chairing the World Bank's International Working Group on financing preparedness, authoring several papers on infectious disease crises, providing policy direction to the UK's National Health Service, and being an active member on both the US National Academy of Science's Committee on Ensuring Access to Affordable Drugs and the Forum on Microbial Threats. Sands has served on various boards and commissions, including as Lead Non-Executive Director of the Department of Health in the United Kingdom, and as a Director of the World Economic Forum.
Dr Bernhard Schwartländer has been appointed Chef de Cabinet. Since 2013, Dr Schwartländer has served as WHO’s representative in China. Before joining WHO in China, he served as Director for Evidence, Policy and Innovation at UNAIDS headquarters in Geneva and as the United Nations Country Coordinator on AIDS in Beijing. He has also held a number of senior international positions including the Director for Performance Evaluation and Policy at the Global Fund to Fight AIDS, TB and Malaria, Director of the WHO’s HIV Department, and Director of Evaluation and Strategic Information at UNAIDS. Prior to joining the United Nations, Dr Schwartländer was the Director of the national AIDS programme in Germany and the Director of the Division of Infectious Disease Epidemiology at the Robert Koch Institute in Berlin, the central biomedical and infectious disease research and reference laboratory of the Federal Ministry of Health, Germany. Dr Schwartländer has published widely in scientific journals and books and taught applied epidemiology in Berlin. He is a medical doctor and holds a doctorate in medical epidemiology. He received his education and professional training in Germany and the United States of America at the Centers for Disease Control and Prevention.
Dr Akihiro Seita is the Director of the Health Department at UNRWA (United Nations Relief and Works Agency for Palestine refugees in the Near East) and the World Health Organization (WHO) Special Representative at UNRWA since November 2010. As the director of health, Dr Seita is the leader in health reform. He successfully converted UNRWA health services to implement best practices based on Universal Health Coverage (UHC) including the introduction of a person-centered family medicine approach, electronic medical records (e-health), and mental health care. Dr Seita is currently the Chair of the UNRWA COVID-19 Coordination Body since February 2020. He takes the lead in developing shared vision and strategy in UNRWA’s overall response to COVID-19 pandemic, and effectively communicate and guide UNRWA directors from all five fields and from different departments to implement and monitor a high-quality response. Dr Seita assumes number of leadership roles in the senior management in UNRWA, including Chair of Advisory Committee on Human Resources (ACHR) to supervise senior staff recruitment process since December 2019, and Interim Delegate for Decision Review (or management review) since January 2020.
Dr. Severoni is the Director of the Global Health and Migration programme, at World Health Organization headquarters. Since 2000 he has held senior positions at the World Health Organization European Office. He is a medical doctor, health economist, epidemiologist and experienced system management.
He has over 24 years of experience as international senior technical advisor and executive, and has worked for, governments, multilateral organizations, NGOs and foundations in Eastern Africa, Balkans, Central Asia and Europe. During his professional career he has dedicated his work to global health with focus to health sector reforms, health system strengthening, health diplomacy, aid coordination/effectiveness, management of complex emergencies and since 2011 directing the public health aspect of migration work for the WHO Regional Office for Europe.
Stéphanie Seydoux has been appointed French Ambassador for Global health in May 2018. She has served as the head of the Women’s Rights and Gender Equality Division, assistant to the Director General of Women’s Affairs and social cohesion from 2014 to 2017. Since November 2017, she was in charge of a support mission to the government for the revision of the bioethics law. After starting her career at the Ministry of Foreign Affairs, Stéphanie Seydoux joined the General Inspectorate of Social Affairs (IGAS) in 2004. From 2007 to 2010, she was head of the department for the promotion of equality at the High commission against discrimination and for equality (HALDE). From 2010 to 2013, she joined the Ministry of Foreign Affairs as first counsellor, deputy head of post at the French Embassy in Kenya.
Päivi Sillanaukee (MD, PhD, eMBA) is the Director-General of the Department of Wellbeing and Services of the Ministry of Social Affairs and Health of Finland. Dr Sillanaukee served as the Permanent Secretary of the Ministry in 2012 - 2019. Between 2008 and 2012, Dr Sillanaukee was the Director General of the Department for Social and Health Services at the Ministry. Previously, she was the Deputy Mayor and Director of Social and Health Services in the City of Tampere, Finland. Between 1990 and 2004, she held clinical and managerial positions in the Pirkanmaa Hospital District and was a member of the Tampere City Council. Dr Sillanaukee is a specialist in public health and management from the University of Helsinki. She has worked on policies to promote public health, social protection and gender equality in the European Union and global levels. She has represented Finland in the WHO Executive Board since May 2018 and is currently serving as its first Vice Chair. She is the co-chair of the Alliance for Health Security Cooperation (AHSC) and a member of the Steering Group of the Global Health Security Agenda.
Mariângela Simão joined WHO in November 2017, as part of Dr Tedros Adhanom Ghebreyesus leadership team. She previously worked for UNAIDS since September 2010 and prior to that, she worked for the Ministry of Health in Brazil as the Director of the Sexually Transmitted Diseases, HIV/ AIDS and Viral Hepatitis department. She worked in the Brazilian public health system since 1982, from the primary health care level to a series of managerial positions throughout the years. As a public health professional, at municipal, state and national levels, she played an active role in the decentralization of the national health system, acquiring an extensive experience in health system strengthening. She has also served on the boards of a number of organizations and government committees related to public health and HIV. Heading the National Sexually Transmitted Diseases/HIV/AIDS Department (including Viral Hepatitis from 2009), she had the responsibility of overseeing and implementing the national Sexually Transmitted Diseases/AIDS/Viral Hepatitis policies, including universal and free of charge access to treatment, care and comprehensive prevention programs. Dr. Simão attended medical school in Brazil, with degrees in Paediatrics and Public Health, and a MSc in Mother and Child Health in the UK.
Dr Princess Nothemba (Nono) Simelela, from South Africa, was most recently WHO's Assistant Director-General for Family, Women, Children and Adolescents. She has more than 30 years of experience as an obstetrician, academic, advocate and government official, and has previously served as Special Advisor to the Vice President of the Republic of South Africa on Social Policy, where she supported the multisectoral, government wide response for HIV. Other previous senior leadership roles held by Dr Simelela include serving as the Chief Executive Officer of the South African National AIDS Council, and as the Director of Technical Knowledge and Support for the International Planned Parenthood Federation. Dr Simelela has presented and published widely on women’s health and contributed to the development of key guidelines on the prevention of mother-to-child transmission of HIV.
Fernando Simón Soria is a Medical Doctor and Epidemiologist trained in Spain, England and France. Fernando Simón is holding the post of Director of the Spanish Coordinating Centre for Health Alerts and Emergencies at the Ministry of Health, Social Services and Equality since 2012. He was researcher at the Spanish Instituto de Salud Carlos III between 2003 and 2011 and previously occupied posts of responsibility in public health and epidemiology sectors in several countries and international organisations in Africa, Latin America and Europe. He has extensive experience in public health surveillance, epidemiology, research, planning preparedness and control of infectious diseases and teaching in different settings at national and international level. Fernando Simón is member of several committees and working groups of the European Union, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization.
Dennis J. Snower is President of the Global Solutions Initiative, which provides policy advice to the G20. He is Senior Research Fellow of the Blavatnik School of Governance, Oxford University; non-resident fellow of The Brookings Institution and visiting Professor at University College, London. Starting in September 2019, he will be Senior Professor at the Hertie School of Governance, Berlin. Furthermore, he is a Research Fellow at the Center for Economic Policy Research (London), at IZA (Institute for the Future of Work, Bonn), and CESifo (Munich). Dennis J. Snower was born in Vienna, Austria, where he went to the American International School. He earned a BA and MA from New College, Oxford University, and an MA and a PhD at Princeton University. He served most recently as President of the Kiel Institute for the World Economy, where he is now a president emeritus, and was previously Professor of Economics at Birkbeck College, University of London.
Agnès Soucat is the Director for Health Systems Governance and Financing at the World Health Organization (WHO) in Geneva, Switzerland. Before joining WHO, she was Global Leader Service Delivery and Lead Economist at the World Bank. Dr. Soucat previously held the position of Director for Human Development for the African Development Bank, where she was responsible for health, education and social protection for 53 African countries. She has over 25 years of experience in health and poverty reduction, covering more than 70 countries in Africa, Asia and Europe. She was a pioneer of several innovations in health care financing including community-based financing and performance-based financing. She was commissioner of the recent Lancet and Rockefeller Commission on Planetary Health. Dr. Soucat holds an MD and a Masters in Nutrition from the University of Nancy in France as well as a Master of Public Health and PhD in Health Economics from the Johns Hopkins University.
Jens Spahn is Germany’s Federal Minister of Health. He is a member of the German Bundestag and part of the center-right party Christian Democratic Union of Germany (CDU), which governs in partnership with the center-left Social Democratic Party of Germany (SPD). Spahn was party speaker for health policy from 2009-2015 and then served as Parliamentary State Secretary to the Federal Minister of Finance before becoming Minister of Health in March 2018.
Frank-Walter Steinmeier was elected as the twelfth President of the Federal Republic of Germany on 12 February 2017. In 1998, he was appointed State Secretary at the Federal Chancellery and Federal Government Commissioner for the Federal Intelligence Services. He also served as Head of the Federal Chancellery from 1999. Frank-Walter Steinmeier was appointed Federal Minister for Foreign Affairs in 2005 and was also Deputy Chancellor from 2007. In 2009, he won a directly elected seat in a constituency in Land Brandenburg and became a Member of the German Bundestag. The parliamentary group of the Social Democratic Party of Germany in the German Bundestag elected him as chairperson. Four years later, he became Federal Minister for Foreign Affairs for the second time, and served in this role until January 2017. Frank-Walter Steinmeier has received numerous awards and prizes, including the Ignatz Bubis Prize for Understanding, the Europe Prize for Political Culture, the Bosphorus Prize for European Understanding, the Willy Brandt Prize, the Tolerance Prize of the Evangelical Academy of Tutzing and the Ecumenical Prize of the Catholic Academy in Bavaria. He has been awarded honorary doctorates by Paderborn University, the Hebrew University of Jerusalem, the University of Piraeus and Ural Federal University of Ekaterinburg. He is also an honorary citizen of the cities of Sibiu and Reims.
Professor Dr med. Hendrik Streeck was born in 1977 in Goettingen. After a year of community service in a hospital in Muenster, he first studied music theory and economics, but then switched to medicine at the Charité in Berlin. In 2007 he did his doctorate at the Friedrich-Wilhelms-Universität Bonn and completed a postdoctoral fellowship at the Partner AIDS Research Center from 2006-2009. In 2009 he was appointed Assistant Professor at the Ragon Institute of MGH, MIT and Harvard and Assistant Immunologist at Massachusetts General Hospital. In 2012 he became the Head of Immunology for the US Military HIV Research Program (MHRP) and Assistant Professor of Emerging Infectious Diseases at the Uniformed Services University of Health Sciences in Washington DC as well as adjunct professor at the Johns Hopkins Bloomberg School of Public Health. In March 2015 he was appointed as full professor and director of Institute for HIV Research at the University of Duisburg-Essen. In 2019 he became the director of the Institute for Virology and the German Center for HIV & AIDS at the Medical Faculty of the University of Bonn. As a specialist in microbiology, virology and infection epidemiology, he became known to a broader public for his commitment and pragmatic voice in combating COVID-19 and advising the federal and state government. In 2019 he was elected Chairman of the Board of Trustees of the German AIDS Foundation.
Dr. Soumya Swaminathan was most recently WHO's Deputy Director-General for Programmes. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience in clinical care and research and has worked throughout her career to translate research into impactful programmes. Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017. In that position, she focused on bringing science and evidence into health policy making, building research capacity in Indian medical schools and forging south-south partnerships in health sciences. From 2009 to 2011, she also served as Coordinator of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases in Geneva. She received her academic training in India, the United Kingdom of Great Britain and Northern Ireland, and the United States of America, and has published more than 350 peer-reviewed publications and book chapters. She is an elected Foreign Fellow of the US National Academy of Medicine and a Fellow of all three science academies in India. She has previously been on several WHO and global advisory bodies and committees.
Mr Sy was Secretary General of the International Federation of Red Cross and Red Crescent Societies (IFRC) from 2014 to 2019. He currently serves as co-Chair of the Global Preparedness Monitoring Board. Prior to his leadership role at the IFRC, Mr Sy was UNICEF’s Director of Partnerships and Resource Development in New York. He has also served as UNICEF Regional Director for Eastern and Southern Africa and Global Emergency Coordinator for the Horn of Africa. Mr Sy held leadership positions with the United Nations Development Programme in New York, with the Global Fund to fight AIDS, Tuberculosis and Malaria and with UNAIDS. Before joining the United Nations, Mr Sy served as Director of Health and Development Programmes with Environment and Development Action in the Third World in Dakar, Senegal. Mr Sy holds a Bachelor’s Degree in Arts and Human Sciences from the University of Dakar. He then pursued Master’s studies in Arts and Germanistik at the University of Graz and graduated from the Diplomatic Academy in Vienna. He was also awarded a postgraduate diploma in Education from the École normale supérieure in Dakar. He speaks English, French and German and is a national of Senegal.
Neera Tanden is the president and CEO of the Center for American Progress and the CEO of the Center for American Progress Action Fund, where she focuses on how both organizations can fulfill their missions to expand opportunity for all Americans. Tanden has also served in both the Obama and Clinton administrations, as well as on presidential campaigns. Before leading American Progress, Tanden was the organization’s chief operating officer. She previously served as senior adviser for health reform at the U.S. Department of Health and Human Services. In that role, she developed policies around reform and worked with Congress and stakeholders on particular provisions of President Barack Obama’s signature legislative achievement—the Affordable Care Act.
Dr. Marta Temido has served as Portugal’s Minister of Health since 2018. She has also served as Chair of the Board of Portugual’s national health system and of several hospitals. Temido holds a PhD in International Health from Universidade Nova de Lisboa, as well as a law degree and master’s degree in health economics and management from the University of Coimbra. She has authored and co-authored several scientific publications on health topics.
Marisol Touraine is a French politician who served as Minister of Social Affairs and Health from 2012-2017, and was elected chair of the Executive Board of Unitaid in 2019. Ms. Touraine is a senior member of the Conseil d’État, France’s highest administrative court, and an international health and social welfare consultant.
In her ministerial post, she worked to improve HIV/AIDS prevention and early diagnosis, promoted universal hepatitis C treatment with innovative drugs, implemented plain tobacco packaging and launched a nutrition labelling system.
Dr. Effy Vayena is Professor of Bioethics at the Swiss Federal Institute of Technology Zürich (ETH Zürich). In her work, she investigates how advances in science can be ethically applied for best outcomes in public and personal health. Vayena completed her education as a social historian with a PhD in Medical History from the University of Minnesota and a habilitation on Bioethics and Health Policy at the University of Zurich. A keen interest in health policy led her to work for the World Health Organization where she served as a technical officer for several years. Upon her return to academia, Vayena was awarded a Swiss National Science Foundation professorship and founded the Health Ethics and Policy Lab. The lab’s purpose is to tackle ethical questions that arise at the cutting edge of biotech research, in areas such as genomic technologies and big data analytics for healthcare. The lab moved to ETH Zurich in 2017.
Ursula von der Leyen is a German politician and has been the first female President of the European Commission since December 2019. She is a member of the Christian Democratic Union (CDU) and the European People's Party (EPP). She has previously served in the federal government of Germany as Federal Minister of Defence, Federal Minister of Labor and Social Affairs as well as Federal Minister for Family Affairs, Senior Citizens, Women and Youth.
Prof. Dr. Veronika von Messling is Director-General for Life Sciences at the German Federal Ministry of Education and Research. She obtained her veterinary degree and her doctorate degree in veterinary virology from the Veterinary School Hannover, Germany. After postdoctoral training at Mayo Clinic in Rochester, MN, she was Assistant Professor at INRS-Institut Armand-Frappier in Laval, QC, and then Associate Professor at Duke-NUS Medical School, Singapore, before becoming Director of the Veterinary Division at Paul-Ehrlich-Institute, the German Federal Institute of Vaccines and Biomedicines, in Langen, Germany.
H.E. Dr. Ifereimi Waqainabete is a Fijian politician and Member of the Parliament of Fiji who is the current Minister for Health and Medical Services in the FijiFirst government. Before entering politics Dr Waqainabete was a general surgeon in Fiji and Associate Professor of General Surgery at Fiji National University, former President of the Fiji Medical Association, President of the Pacific Island Surgeons Association, and former Chairman of Fiji Medicinal Board. He was on leave from his academic and surgical duties to partake in the 2018 election as a candidate for the Fiji First Party.
Prof. Lothar H. Wieler is president of the Robert Koch Institute, the national public health institute in Germany. The Robert Koch Institute is in charge of health monitoring and surveillance, pandemic preparedness, and preventing and recognizing attacks with biological agents. Prof. Wieler's own research focus has been zoonoses, particularly on molecular mechanisms, enabling bacterial pathogens to infect different hosts, and develop antibiotic resistance. He is author/co-author of more than 220 peer-reviewed papers. Wieler is also deputy spokesperson of the intersectoral research consortium InfectControl 2020 and a member of the scientific advisory board of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), the WHO Europe Advisory Committee on Health Research (EACHR), and the WHO Strategic and Technical Advisory Group on Infectious Hazards (STEG-IH). Since 2010, he is an elected member of the German National Academy of Sciences.
Dow R. Wilson is president and chief executive officer of Varian Medical Systems. Varian designs and manufactures advanced equipment and software products for treating cancer with radiation. Mr. Wilson is also a member of the company's Board of Directors. Since joining Varian in 2005, Mr. Wilson has held key executive positions with the company. Prior to being appointed CEO in 2012, he served as executive vice president and chief operating officer and president of Varian’s Oncology Systems business. Mr. Wilson joined Varian following a 19-year career with General Electric in a variety of senior management positions. He served as CEO for GE Healthcare-Information Technologies, a business that included all of GE Healthcare’s IT businesses plus anesthesia, cardiac, and neonatal monitoring units. Prior to that, he was general manager for a number of GE’s imaging businesses, including the X-Ray, Nuclear Medicine, Computed Tomography (CT), and Positron Emission Tomography businesses. He is also on the Board of Directors at Agilent, AdvaMed (MedTech trade association), and the US-India Strategic Partnership Forum. In 2014, he was appointed by US Secretary of Commerce, Penny Pritzker, to the President’s Advisory Council on Doing Business in Africa. He was recently named Chairman of the USA-Brazil CEO Forum by Secretary of Commerce, Wilbur Ross.
Sir Andrew Witty was named president, UnitedHealth Group, in November 2019, in addition to his role as chief executive officer of Optum. As UnitedHealth Group president, Sir Andrew is responsible for enterprise business strategy formulation, enterprise business development and partnerships, and oversight of enterprise research and development and clinical capacities. Witty was named executive vice president, UnitedHealth Group, and chief executive officer, Optum, in March 2018. He is also a member of the Office of the Chief Executive and previously served as a UnitedHealth Group company director. From 2008 to 2017, Witty was chief executive officer and a director of the leading pharmaceutical manufacturer GlaxoSmithKline (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe. Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Prime Minister’s Research, Innovation and Enterprise Council. He is an advisor to 8VC and Hatteras Venture Partners, as well as to the Bill and Melinda Gates Foundation. Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an Honorary Citizen by Singapore for his contributions to the country’s growth and development. Witty recently took a leave of absence from his current role as president, UnitedHealth Group and CEO of Optum to co-lead the World Health Organization (WHO) COVID-19 vaccine program.
Alicia Ely Yamin is currently Senior Fellow at Harvard Law School; and Senior Advisor on Human Rights at Partners in Health. Yamin’s 30 -year career at the intersection of global health and human rights has bridged academia and activism. Yamin has lived and worked in Latin America and East Africa for half of her professional life, working with and through local advocacy organizations. In 2016, the UN Secretary General appointed Yamin as one of ten international experts to the Independent Accountability Panel (IAP) for the SDGs. She also serves on the WHO’s Technical Advisory Group on Health Technology Assessments, as well as the Lancet Commission on Arctic Health and the Expert Working Group on Global Public Investment.
Dr Moneef R. Zou’bi has been an advocate of Science and Technology for Development for around 30 years. Born in Amman, Jordan, he studied for his undergraduate and postgraduate degrees in Civil Engineering Technology and Managementat Brighton and Loughborough Universities in the United Kingdom, 1980 - 1987. After becoming involved in global development issues, he successfully pursued further post-graduate work at the Department of Science and Technology Studiesat the University of Malaya. Moneef joined the Islamic World Academy of Sciences (IAS) (an international scientific NGO based in Jordan and affiliated to the Organisation of Islamic Co-operation (OIC)) in 1990, embarking on a career in international scientific and technological collaboration involving more than 57 countries. After serving in various capacities at the IAS, he was appointed by the IAS Council as Director General, IAS, in May 1998. He also serves as the Science Advisor to the InterAction Council (IAC) which is an independent international organization that mobilizes the experience and international contacts of a group of statesmen who have held the highest office in their own countries. Over the last three decades, he has been involved in scientific missions in more than 30 countries.